As AstraZeneca braces for the impact of the U.S. “most favored nation” drug pricing policy, CEO Pascal Soriot suggests that a “very conservative” way to model the fallout would be removing the eight ...

AstraZeneca is giving Pascal Soriot a pay raise as the longtime CEO weathered a year of “significant geopolitical uncertainty” to advance the British pharma toward an ambitious 2030 goal. For 2025, ...

AstraZeneca and GSK, the U.K.'s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.

The boss of drug giant AstraZeneca has warned that the UK is deterring investment from the pharma industry. Chief executive Pascal Soriot said Britain should be trying to attract cash from the sector ...

Cambridge is to benefit hugely from a U-turn by Pharma giant AstraZeneca which has decided to go ahead with a £300 million expansion of facilities at the city's Biomedical Campus after mothballing the ...

AstraZeneca CEO Pascal Soriot joins 'Mad Money' host Jim Cramer to talk manufacturing expansion, growth plans, next-gen therapies, and more. Got a confidential news tip? We want to hear from you. Sign ...

Drugmaker had stalled large-scale projects in England but has now pledged investment at two sites, announced by Keir Starmer ...

WASHINGTON — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump ...

AstraZeneca says its new building in Cambridge will soon be completed.

AstraZeneca has announced a £300m investment package in Britain after Sir Keir Starmer agreed to pay more for cutting-edge drugs within the NHS.